NEET-PG 2015 - Biochemistry Practice Questions

Q: In the malate shuttle, how many ATPs are produced from one NADH?

2.5 ATP. ***2.5 ATP*** - In the **malate-aspartate shuttle**, mitochondrial **NADH** is regenerated from cytosolic NADH, and then enters the electron transport chain at **Complex I**. - **Complex I** entry means that NADH contributes to the pumping of enough protons to generate approximately **2.5 ATP** through oxidative phosphorylation. *1 ATP* - **1 ATP** is not the direct equivalent produced from the reoxidation of one NADH via the malate shuttle into the electron transport chain. - This value is typically associated with the direct hydrolysis of **ATP** or the energy equivalent of **GTP** produced in the citric acid cycle. *3 ATP* - Historically, **3 ATP** was the accepted stoichiometry for one NADH, but more accurate measurements of proton pumping and ATP synthase activity have revised this. - The value of 3 ATP per NADH does not reflect the most current understanding of mitochondrial bioenergetics. *2 ATP* - **2 ATP** is the approximate yield for **FADH2** entering the electron transport chain at **Complex II**, bypassing Complex I, and thus pumping fewer protons. - This value is not applicable to NADH transferred via the malate-aspartate shuttle, as NADH enters at Complex I.

Q: Chymotrypsinogen is activated into chymotrypsin by:

Trypsin. ***Activation of Chymotrypsinogen by Trypsin*** - **Trypsin** is the primary enzyme responsible for the activation of **chymotrypsinogen** into its active form, **chymotrypsin**, by cleaving a specific peptide bond. - This activation is part of a cascade of proteolytic enzyme activations in the **pancreatic juice**, crucial for protein digestion in the small intestine. *Pepsin* - **Pepsin** is a protease active in the **stomach**, requiring an acidic environment for its activity, and is involved in the initial breakdown of proteins. - It does not play a role in the activation of pancreatic zymogens like chymotrypsinogen; its primary function is protein digestion in the gastric lumen. *Renin* - **Renin** is an enzyme primarily involved in the **renin-angiotensin-aldosterone system** (RAAS), which regulates blood pressure and fluid balance. - Its action involves cleaving **angiotensinogen** to form angiotensin I, and it has no role in the activation of digestive enzymes like chymotrypsinogen. *HCl* - **Hydrochloric acid (HCl)** is produced in the stomach and is essential for providing the acidic environment required for **pepsin's activity** and for denaturing proteins. - While HCl is crucial for digestion, it does not directly activate chymotrypsinogen; this activation is an enzymatic process carried out by another protease.

Q: Which coenzyme is not required in the formation of glutamate?

Thiamine pyrophosphate. ***Thiamine pyrophosphate*** - **Thiamine pyrophosphate (TPP)** is a coenzyme derived from **vitamin B1** that is essential for reactions involving decarboxylation, such as those catalyzed by pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. - The formation of glutamate primarily involves transamination or reductive amination, which do not require TPP. *Pyridoxal phosphate* - **Pyridoxal phosphate (PLP)**, derived from **vitamin B6**, is a crucial coenzyme for **transamination reactions**, which are a major pathway for glutamate synthesis (e.g., from alpha-ketoglutarate). - It also plays a role in decarboxylation and deamination reactions of amino acids. *Niacin* - **Niacin (vitamin B3)** is a precursor for **NAD+** and **NADP+**, which are essential coenzymes in many metabolic pathways. - **NADPH**, derived from NADP+, is required as a reductant in the **reductive amination** of **alpha-ketoglutarate** to form glutamate, catalyzed by glutamate dehydrogenase. *None of the above* - This option is incorrect because **thiamine pyrophosphate** is indeed not required for the formation of glutamate. - The other two coenzymes, **pyridoxal phosphate** and **niacin (as NAD(P)H)**, are involved in glutamate synthesis.

Q: What type of receptor is the insulin receptor?

Tyrosine kinase. ***Tyrosine kinase*** - The insulin receptor is a **receptor tyrosine kinase (RTK)**, meaning it has intrinsic tyrosine kinase activity that phosphorylates specific tyrosine residues on itself and other intracellular proteins upon insulin binding. - This phosphorylation initiates a **signaling cascade** involving molecules like IRS proteins, PI3K/Akt, and MAPK pathways, leading to glucose uptake and metabolic regulation. *Guanylyl cyclase* - Guanylyl cyclase receptors, such as the **atrial natriuretic peptide receptor**, catalyze the conversion of GTP to **cGMP**, which acts as a second messenger. - This mechanism is distinct from the insulin receptor's direct protein phosphorylation. *Adenylyl cyclase* - Adenylyl cyclase is typically activated by **G-protein coupled receptors (GPCRs)**, leading to the conversion of ATP to **cAMP**, another second messenger. - The insulin receptor does not couple to G proteins or directly activate adenylyl cyclase. *IP3-DAG* - The **inositol triphosphate (IP3)** and **diacylglycerol (DAG)** pathway is primarily activated by certain **GPCRs** and involves the hydrolysis of PIP2 by phospholipase C, leading to calcium release and protein kinase C activation. - This pathway is not the primary signaling mechanism initiated by the insulin receptor.

Q: Enzyme deficient in Hers disease -

Liver phosphorylase. ***Liver phosphorylase*** - Hers disease, also known as Glycogen Storage Disease Type VI, is specifically caused by a deficiency of **liver phosphorylase**. - This enzyme is crucial for the breakdown of **glycogen in the liver**, leading to an inability to release glucose into the bloodstream during fasting. *Muscle phosphorylase* - Deficiency of **muscle phosphorylase** (myophosphorylase) causes **McArdle disease** (Glycogen Storage Disease Type V), which primarily affects muscle energy. - Patients typically present with exercise intolerance, muscle pain, and cramps, not the hepatic symptoms seen in Hers disease. *Acid maltase* - Deficiency of **acid maltase** (also known as alpha-glucosidase) is responsible for **Pompe disease** (Glycogen Storage Disease Type II), a lysosomal storage disorder. - This enzyme deficiency leads to glycogen accumulation in lysosomes in various tissues, including muscle, liver, and heart, causing muscle weakness and cardiomyopathy. *Debranching enzyme* - A deficiency in the **debranching enzyme** (amylo-1,6-glucosidase) causes **Cori disease** or **Forbes disease** (Glycogen Storage Disease Type III). - This results in the accumulation of abnormally structured glycogen with short outer branches in the liver, muscle, and heart.

Q: Amide group is present in which part of protein?

Peptide bond. ***Peptide bond*** - A **peptide bond** is formed between the **carboxyl group** of one amino acid and the **amino group** of another, releasing a water molecule. This bond has an **amide structure**. - The repeated formation of these amide (peptide) bonds links amino acids into long chains, forming a **polypeptide** or protein. *Amino-terminal* - The **amino-terminal (N-terminal)** end of a protein contains a free **amino group (-NH2)**, which is not part of an amide linkage within the polypeptide backbone. - It marks the beginning of the polypeptide chain and is typically involved in various cellular interactions and modifications. *Disulfide bond* - A **disulfide bond** is a covalent bond formed between two **sulfhydryl groups (-SH)** of **cysteine residues**, leading to the formation of a **cystine** residue. - This bond is crucial for stabilizing the **tertiary and quaternary structures** of proteins, but it does not contain an amide group. *Carboxy-terminal* - The **carboxy-terminal (C-terminal)** end of a protein contains a free **carboxyl group (-COOH)**, which is not part of an amide linkage within the polypeptide backbone. - It marks the end of the polypeptide chain and plays roles in protein processing, targeting, and regulation.

Q: What is the primary role of calnexin and calreticulin in the endoplasmic reticulum?

Act as chaperones. ***Act as chaperones*** - **Calnexin** and **calreticulin** are **chaperone proteins** located in the **endoplasmic reticulum (ER)**. - They bind to unfolded or misfolded glycoproteins to assist in their proper folding and assembly. - They are part of the **ER quality control system**, ensuring only properly folded proteins proceed to the Golgi apparatus. *Degrade misfolded proteins* - While misfolded proteins are eventually degraded through **ER-associated degradation (ERAD)**, this is not the primary function of calnexin and calreticulin. - These chaperones first attempt to **rescue and refold** proteins; degradation is a separate process involving other machinery. *Serve as tumor markers* - **Calnexin** and **calreticulin** are not typically used as **tumor markers** in clinical practice. - Their functions are related to protein quality control within the cell, not cancer detection. *Facilitate enzymatic reactions* - While some proteins in the ER are enzymes, **calnexin** and **calreticulin** themselves are not enzymes, nor do they primarily facilitate enzymatic reactions. - Their function is to ensure correct protein folding, distinct from direct catalytic activity.

Q: Which of the following statements about the enzymes involved in the conversion of glucose to glucose-6-phosphate in glycolysis is true?

Glucokinase is induced by insulin.. ***Glucokinase is induced by insulin.*** - **Insulin** promotes glucose uptake and utilization in the liver and pancreatic beta cells, where glucokinase is primarily expressed. - Induction of **glucokinase** by insulin ensures that glucose is efficiently phosphorylated and trapped within hepatocytes when blood glucose levels are high. - This is a key mechanism for postprandial glucose homeostasis. *Incorrect: Hexokinase is specific for glucose.* - **Hexokinase** is NOT specific for glucose; it can phosphorylate various hexoses including **fructose**, **mannose**, and **galactose**. - Its broad substrate specificity distinguishes it from glucokinase, which has greater specificity for glucose. *Incorrect: Glucokinase is inhibited by glucose-6-phosphate.* - Unlike **hexokinase**, which is subject to product inhibition by glucose-6-phosphate, **glucokinase is NOT inhibited** by its product. - This lack of feedback inhibition allows glucokinase to continue phosphorylating glucose even when glucose-6-phosphate levels are elevated, which is appropriate for its role as a glucose sensor in liver and pancreatic beta cells. *Incorrect: Hexokinase has a high Km for glucose.* - **Hexokinase** has a **low Km** (~0.1 mM) for glucose, meaning it has high affinity and is saturated at normal blood glucose levels. - In contrast, **glucokinase** has a high Km (~10 mM), allowing it to respond proportionally to changes in blood glucose concentration.

Q: What is the estimated blood glucose level in mg/dL for a patient with an HbA1c of 8% based on the conversion formula?

200. ***200*** - The estimated average glucose (eAG) can be calculated from HbA1c using the formula: **eAG (mg/dL) = 28.7 × HbA1c (%) – 46.7**. - For an HbA1c of 8%, the calculation is: **28.7 × 8 – 46.7 = 229.6 – 46.7 = 182.9 mg/dL**, which is closest to 200 mg/dL among the given options. *120* - An eAG of 120-125 mg/dL would correspond to an **HbA1c between 5.8% and 6.0%**, which is below the given 8%. - This value typically reflects **well-controlled or pre-diabetic** blood glucose levels. *160* - An eAG of 160 mg/dL would correspond to an **HbA1c of approximately 7.0-7.2%**, which is lower than the given 8%. - This level is often the target for HbA1c in many **diabetic management guidelines**, but not for 8%. *240* - An eAG of 240 mg/dL would correspond to an **HbA1c of approximately 9.9%**, which is significantly higher than the given 8%. - This indicates **poorly controlled diabetes** and a much higher average blood glucose level.

Q: Unfolded protein metabolism is associated with

Endoplasmic reticulum. ***Endoplasmic reticulum*** - The **endoplasmic reticulum (ER)** is the primary site for protein folding, modification, and assembly, especially for secreted and transmembrane proteins. - When misfolded proteins accumulate, the ER triggers the **unfolded protein response (UPR)** to restore homeostasis or induce apoptosis. *Golgi apparatus* - The Golgi apparatus is primarily involved in **further processing**, sorting, and packaging of proteins and lipids synthesized in the ER. - It does not directly manage the initial folding of proteins or the response to widespread protein misfolding. *Mitochondria* - **Mitochondria** are known for their role in **energy production** (ATP synthesis) through cellular respiration. - While they possess their own protein synthesis machinery for some essential mitochondrial proteins, they are not involved in the overall cellular management of unfolded protein metabolism from the ER.

Question 1

In the malate shuttle, how many ATPs are produced from one NADH?

Accepted Answer

2.5 ATP

Answer

1 ATP

Answer

3 ATP

Answer

2 ATP

Question 2

Chymotrypsinogen is activated into chymotrypsin by:

Accepted Answer

Trypsin

Answer

Pepsin

Answer

Renin

Answer

HCl

Question 3

Which coenzyme is not required in the formation of glutamate?

Accepted Answer

Thiamine pyrophosphate

Answer

None of the above

Answer

Pyridoxal phosphate

Answer

Niacin

Question 4

What type of receptor is the insulin receptor?

Accepted Answer

Tyrosine kinase

Answer

Guanylyl cyclase

Answer

Adenylyl cyclase

Answer

IP3-DAG

Question 5

Enzyme deficient in Hers disease -

Accepted Answer

Liver phosphorylase

Answer

Muscle phosphorylase

Answer

Acid maltase

Answer

Debranching enzyme

Question 6

Amide group is present in which part of protein?

Accepted Answer

Peptide bond

Answer

Amino-terminal

Answer

Disulfide bond

Answer

Carboxy-terminal

Question 7

What is the primary role of calnexin and calreticulin in the endoplasmic reticulum?

Accepted Answer

Act as chaperones

Answer

Degrade misfolded proteins

Answer

Serve as tumor markers

Answer

Facilitate enzymatic reactions

Question 8

Which of the following statements about the enzymes involved in the conversion of glucose to glucose-6-phosphate in glycolysis is true?

Accepted Answer

Glucokinase is induced by insulin.

Answer

Hexokinase is specific for glucose.

Answer

Glucokinase is inhibited by glucose-6-phosphate.

Answer

Hexokinase has a high Km for glucose.

Question 9

What is the estimated blood glucose level in mg/dL for a patient with an HbA1c of 8% based on the conversion formula?

Accepted Answer

200

Answer

120

Answer

160

Answer

240

Question 10

Unfolded protein metabolism is associated with

Accepted Answer

Endoplasmic reticulum

Answer

Golgi apparatus

Answer

Mitochondria

NEET-PG 2015 — Biochemistry